- Progression Within 24 Months Predicts Poorer Survival Following Relapse or Progression in Follicular Lymphoma
- Low/Intermediate FLIPI and Not Transformed Follicular Lymphoma Has a Favorable Outcome
- In Follicular Lymphoma, What are the Risk Factors for Histological Transformation?
- Biomarkers in Follicular Lymphoma
- Understanding Duodenal-type Follicular Lymphoma
- Q&A: Sendhilnathan Ramalingam, MD, on Follicular Lymphoma Prognosis
- Q&A: Thomas S.C. Ng, MD, PhD, and Antonio R. Lopez on Neurolymphomatosis in Diffuse Large B-cell Lymphoma
- Q&A: Jeff R. Gehlhausen, MD, PhD, on Random Skin Biopsies in the Diagnosis of Intravascular Large B-cell Lymphoma
- Q&A: Shyam A. Patel, MD, PhD, on DLBCL — Where We Are and Where We’re Headed